Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Mostrar mais
Pergunte à ADVFN Intelligence (IA)
| Período | Var | Var % | Abe | Máx. | Mín. | Vol Méd. | VWAP diário | |
|---|---|---|---|---|---|---|---|---|
| 1 | -4.591 | -7.20948492462 | 63.68 | 63.69 | 57.75 | 4772109 | 60.27912606 | CS |
| 4 | -19.961 | -25.2511068944 | 79.05 | 79.88 | 57.75 | 6558698 | 66.4378878 | CS |
| 12 | -64.031 | -52.0069850552 | 123.12 | 126.4199 | 57.75 | 4842120 | 79.00645791 | CS |
| 26 | -46.811 | -44.2030217186 | 105.9 | 170.47 | 57.75 | 4366830 | 104.06739262 | CS |
| 52 | -43.641 | -42.4812615594 | 102.73 | 170.47 | 57.75 | 4474960 | 98.02197977 | CS |
| 156 | -240.231 | -80.2589202192 | 299.32 | 376.4118 | 57.75 | 5395161 | 160.77743513 | CS |
| 260 | 43.759 | 285.446836269 | 15.33 | 497.17 | 13.53 | 9040130 | 148.08170466 | CS |
Suporte: (11) 4950 5808 | suporte@advfn.com.br
Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições
Recursos principais
Premium
